CatalystEarnings

$RMD (RESMED) — 8-K: RMD Q4 FY26 EPS $2.95 beats consensus by +1.7%

RMD

$240.33

+1.94%

What changed

Adjusted EPS of $2.95 topped the $2.90 consensus by $0.05 (+1.7%). Revenue reached $1,464M, up 8.6% YoY. No guidance figures were provided.

Why it matters

Adjusted EPS of $2.95 topped the $2.90 consensus by $0.05 (+1.7%). Revenue reached $1,464M, up 8.6% YoY. No guidance figures were provided.

Sources